Drug interaction concerns may affect HIV treatment adherence among transgender women
(NIH/National Institute of Allergy and Infectious Diseases) Transgender women -- at high risk of HIV acquisition -- are a key population for HIV prevention and treatment efforts. A study supported by NIH and Gilead Sciences reveals that more than half of transgender living with HIV in Los Angeles were concerned that taking both antiretroviral therapy to treat HIV and feminizing hormone therapy (HT) may cause harmful drug-drug interactions. Many surveyed cited these concerns as a reason for not taking anti-HIV medications, HT, or both. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 24, 2017 Category: International Medicine & Public Health Source Type: news

Additional studies needed to evaluate CVD risks of hormone therapy for transgender patients
(Brigham and Women's Hospital) Additional studies needed to evaluate cardiovascular disease risks of long-term, hormone therapy for transgender patients (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 24, 2017 Category: International Medicine & Public Health Source Type: news

Updated position on hormone therapy for menopause
Andrew Kaunitz, professor in the Department of Obstetrics and Gynecology at the University of Florida College of Medicine, discusses new guidance from the North American Menopause Society on hormone therapy.Medscape (Source: Society for Endocrinology)
Source: Society for Endocrinology - July 18, 2017 Category: Endocrinology Source Type: news

What to Know About the NAMS Updated Position on Hormone Therapy What to Know About the NAMS Updated Position on Hormone Therapy
Systemic HT is an appropriate choice for symptomatic women in their 50s or within 10 years of the onset of menopause, Dr Kaunitz says.Medscape Ob/Gyn (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 17, 2017 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Commentary Source Type: news

Does coffee make you live longer?
Conclusion This study, conducted on a large number of people across Europe, was backed up by similar findings in the US. It appears to show some association between people who drink higher amounts of coffee and a reduced risk of death. But the "potentially beneficial clinical implications" need to be considered carefully for a number of reasons: Although the analyses were adjusted for some confounding variables, there may be a number of other factors that differ between the groups that account for the differences in death, such as socioeconomic status, family history, other medical conditions, and use of medic...
Source: NHS News Feed - July 12, 2017 Category: Consumer Health News Tags: Food/diet Source Type: news

Opera singer Lesley Garrett's voice 'saved by HRT'
English opera singer Lesley Garrett said menopause hormone therapy drug HRT has 'saved her voice' after she started taking it 20 years ago to battle symptoms including hot flushes and headaches. (Source: the Mail online | Health)
Source: the Mail online | Health - July 12, 2017 Category: Consumer Health News Source Type: news

Caster Semenya could be forced to undertake hormone therapy for future Olympics
Study shows performance-boosting effects of testosterone in female athletes, reopening controversial debate about intersex and hyperandrogenous competitorsUsing testosterone to categorise male and female athletes isn ’t perfect, but it’s the best solution we haveCaster Semenya, the Olympic 800m champion, may be banned from competing at future Games unless she undergoes hormone replacement therapy (HRT) or even surgery in the wake of a landmark study into athletes with raised testosterone levels which has just been published.The International Association of Athletics Federations, the world governing body, commis...
Source: Guardian Unlimited Science - July 4, 2017 Category: Science Authors: Martha Kelner and James Rudd Tags: Athletics Caster Semenya IAAF Sport Science World news Olympic Games Sport politics Gender Source Type: news

Using testosterone to categorise male and female athletes isn't perfect, but it's the best solution we have | Joanna Harper
An important new study could lead to the reinstatement of rules imposing a maximum level of male sex hormones in athletes competing as femaleCaster Semenya could be forced to undertake hormone therapy for future OlympicsWhile it has long been recognised that testosterone (T) level differences are the principle cause of the athletic advantage that men hold over women, there has been little published data indicating that T differences among women can result in significant advantage for those with higher T.This lack of scientific data was one of the main reasonsthe CAS panel issued a temporary ruling in favour of Dutee Chand ...
Source: Guardian Unlimited Science - July 4, 2017 Category: Science Authors: Joanna Harper Tags: Athletics Gender IAAF Sport Sport politics World news Science Source Type: news

Don't Be Nervous About Hormone Therapy for Menopause, Says NAMS Don't Be Nervous About Hormone Therapy for Menopause, Says NAMS
The North American Menopause Society released a new statement on the use of hormone therapy for menopause, promising to make healthcare providers more confident about treating symptomatic women who want it.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 30, 2017 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Fuji Pharma to market Mithra's hormone therapy Donesta in Japan and ASEAN
Belgium-based pharmaceutical company Mithra has signed an exclusive license and supply agreement (LSA) with Japanese firm Fuji Pharma for the commercialisation of Donesta in Japan and Association of South-East Asian Nations (ASEAN) territories. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - June 29, 2017 Category: Pharmaceuticals Source Type: news

Luteolin: How To Reduce Breast Cancer Risk
More than 100 women die of breast cancer in the U.S. every day. It's the second leading cause of cancer deaths in American women. But in my opinion, many of those women really die of a tragic medical error. Let me explain… Millions of women in the U.S. have taken Big Pharma's hormone replacement therapy (HRT). Their doctors prescribe it to try to relieve the symptoms of menopause. Like hot flashes, night sweats, mood swings and weight gain. But what the drug companies try to pass off as hormones are actually synthetic concoctions. They are fake versions of the estrogen and progesterone that your body makes ...
Source: Al Sears, MD Natural Remedies - June 23, 2017 Category: Complementary Medicine Authors: Al Sears Tags: Anti-Aging Source Type: news

Women losing out over hormone therapy fears, some experts say
The risk of heart attack, stroke or breast cancer due to hormone replacement therapy has been overstated, and that has scared away some women who could benefit from it, the Society of Obstetricians and Gynaecologists of Canada said at its annual conference in Ottawa this week. (Source: CBC | Health)
Source: CBC | Health - June 23, 2017 Category: Consumer Health News Tags: News/Health Source Type: news

NAMS new position statement on hormone therapy to relieve menopause symptoms
A new position statement on the use of hormone therapy for menopause symptoms from The North American Menopause Society (NAMS) has been published online inMenopause.News Medical (Source: Society for Endocrinology)
Source: Society for Endocrinology - June 21, 2017 Category: Endocrinology Source Type: news

Preventing Bone Loss in Functional Hypothalamic Amenorrhea Preventing Bone Loss in Functional Hypothalamic Amenorrhea
What does the evidence tell us about the effectiveness of hormonal therapy and bisphosphonates for preventing bone loss among these patients?Journal of the Endocrine Society (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 21, 2017 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

Hormone Therapy: Updated Position Statement Released (FREE)
By Joe Elia Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM The North American Menopause Society has updated its position on the risks and benefits of hormone therapy.The 26-page statement evaluates … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - June 21, 2017 Category: Primary Care Source Type: news

NAMS 2017 position statement updates guidelines for hormone therapy use
(The North American Menopause Society (NAMS)) A position statement on the use of hormone therapy for menopausal and postmenopausal women from The North American Menopause Society (NAMS) has been published online in Menopause. 'The goal of the Society's position statement is to provide excellent, evidence-based, current clinical recommendations to menopause practitioners for the improvement of care for women depending on them to help relieve menopause symptoms,' says Dr. JoAnn Pinkerton, NAMS executive director. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 20, 2017 Category: Cancer & Oncology Source Type: news

Drinking May Hike Muscle-Wasting After Menopause (CME/CE)
(MedPage Today) -- Estrogen hormone therapy seen as possibly mitigating this risk (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - June 7, 2017 Category: Endocrinology Source Type: news

Prostate cancer trial shows improved survivability with additional hormone therapy
The Phase II/III clinical trial (STAMPEDE) currently being conducted by the University of Birmingham, UK, has demonstrated improved survivability of 37% with the use of an additional hormone therapy to treat prostate cancer patients. (Source: Drug Development Technology)
Source: Drug Development Technology - June 7, 2017 Category: Pharmaceuticals Source Type: news

Diabetes Risk in Adulthood After GH Treatment in Childhood Diabetes Risk in Adulthood After GH Treatment in Childhood
Are patients treated with growth hormone therapy for short stature in childhood at a greater risk for diabetes later in life?Journal of Clinical Endocrinology & Metabolism (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 6, 2017 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

10 Facts Women Should Know About Endometrial Cancer
The most common cancer of the reproductive organs in American women is endometrial cancer. The American Cancer Society estimates that for the year 2017, around 61,380 new cases of cancer of the body of the uterus will be diagnosed and about 10,920 women will die from cancers of the uterine body. These figures include both endometrial cancers and uterine sarcomas. Since endometrial cancer is a fairly common cancer in women, the more women know the facts about this disease, the greater their chance of knowing what symptoms to be aware of in order to have it diagnosed as early as possible, improving the likelihood of surviva...
Source: Healthy Living - The Huffington Post - June 5, 2017 Category: Consumer Health News Source Type: news

Drugs Score Big Wins Against Lung, Prostate, Breast Cancers
CHICAGO (AP) — Drugs are scoring big wins against common cancers, setting new standards for how to treat many prostate, breast and lung tumors. There’s even a “uni-drug” that may fight many forms of the disease. What’s striking: The drugs are beneficial in some cases for more than a year, much longer than the few months many new drugs provide. Here are highlights from the world’s largest cancer meeting, the American Society of Clinical Oncology conference in Chicago. PROSTATE CANCER Janssen Biotech’s Zytiga improved survival and delayed cancer growth for 18 months when added to sta...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - June 5, 2017 Category: Consumer Health News Authors: Health – CBS Boston Tags: Breast Cancer Health News Prostate Cancer Source Type: news

Early use of J & J's Zytiga extends prostate cancer survival
CHICAGO (Reuters) - Adding Johnson& Johnson's Zytiga to standard hormone therapy reduced by nearly 40 percent the chance of death for men newly diagnosed with high-risk prostate cancer that had spread to other parts of the body, according to new trial results. (Source: Reuters: Health)
Source: Reuters: Health - June 3, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Drug Extends Lives of Patients With Advanced Prostate Cancer: Studies
SATURDAY, June 3, 2017 -- Men with advanced prostate cancer might be able to avoid chemotherapy by taking an additional anti-testosterone pill along with standard hormone therapy, a pair of new clinical trials show. The drug, abiraterone (Zytiga),... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 3, 2017 Category: General Medicine Source Type: news

Study shows early Zytiga use improves prostate cancer survival
CHICAGO (Reuters) - Adding Johnson& Johnson's Zytiga to standard hormone therapy reduced by nearly 40 percent the risk of death for men newly diagnosed with prostate cancer that had spread to other parts of the body, according to new trial results. (Source: Reuters: Health)
Source: Reuters: Health - June 3, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Adding abiraterone to standard treatment improves prostate cancer survival by 40 percent
(Cancer Research UK) Adding abiraterone to hormone therapy at the start of treatment for prostate cancer improves survival by 37 percent, according to the results of one of the largest ever clinical trials for prostate cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 3, 2017 Category: Cancer & Oncology Source Type: news

Growth hormone therapy enhances recovery of patients with spinal damage
Growth hormone treatment combined with physical therapy over six months significantly improved sensory function in patients with complete spinal injuries, according to research presented at the European Congress of Endocrinology in Lisbon.Science Daily (Source: Society for Endocrinology)
Source: Society for Endocrinology - May 25, 2017 Category: Endocrinology Source Type: news

Expanding waistline linked to an increased risk of cancer
Conclusion This study provides more evidence of the link between excess body fat and 10 cancers. Though the percentage increases sound large, it's important to put these results into context. For example, the baseline risk of postmenopausal cancer was 2.2% – it occurred in 555 of the 24,751 women in the study. For women who hadn't used hormone therapy, this would increase to a risk of 2.7% if they had a BMI of 30 compared with 26, or a waist circumference of 95cm compared with 84cm. This accounts for only an extra 5 cases in every 1,000 women. This large study involved older adults from European countries, so ...
Source: NHS News Feed - May 25, 2017 Category: Consumer Health News Tags: Cancer Obesity Source Type: news

When Your Doctor Prescribes A Vibrator For Your Aging Vagina
Doctors have been adding a new tool to the arsenal of how they restore the sex lives of menopausal and post-menopausal women: the humble vibrator. With the onset of menopause, a decrease in the production of hormones causes vaginal tissue to get thinner and drier. Vaginal muscles can also atrophy, leading to painful sex ― a problem for half of all menopausal and post-menopausal women, according to the National Institutes of Health. But the solution might be as simple as a vibrating piece of silicon.  Vibrators that are used internally stimulate pelvic blood flow, which increases vaginal mois...
Source: Healthy Living - The Huffington Post - May 18, 2017 Category: Consumer Health News Source Type: news

Hormone Therapy Not Advised for Preventing Disease After Menopause
Title: Hormone Therapy Not Advised for Preventing Disease After MenopauseCategory: Health NewsCreated: 5/16/2017 12:00:00 AMLast Editorial Review: 5/17/2017 12:00:00 AM (Source: MedicineNet Menopause General)
Source: MedicineNet Menopause General - May 17, 2017 Category: Primary Care Source Type: news

USPSTF Maintains Stance Against Using Hormone Therapy to Prevent Chronic Conditions (FREE)
By Amy Orciari Herman Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM The U.S. Preventive Services Task Force, in a draft recommendation statement, is again advising against the use … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - May 17, 2017 Category: Primary Care Source Type: news

Hormone Therapy Not Advised for Preventing Disease After Menopause
Benefits of treatment don't outweigh the risks, U.S. task force reiterates Source: HealthDay Related MedlinePlus Pages: Hormone Replacement Therapy (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - May 16, 2017 Category: Consumer Health News Source Type: news

Hormone Therapy Not Advised for Preventing Disease After Menopause
TUESDAY, May 16, 2017 -- Using hormone therapy to prevent chronic health issues, such as heart disease and bone loss, in postmenopausal women may do more harm than good, the U.S. Preventive Services Task Force (USPSTF) says. After reviewing current... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 16, 2017 Category: General Medicine Source Type: news

6 Signs You Should Talk To A Doctor About Fertility
Andrea Syrtash was first hospitalized at the age of 14 for painful and heavy menstrual cycles due to endometriosis. She had no idea her condition would affect her fertility ― and even if she had known, she may not have thought to address it without guidance from her doctors. After six years of trying to conceive, Syrtash, who’s now in her 40s and works as a relationship and dating expert, recently founded pregnantish, a website for singles, couples and LGBTQ people who are trying to conceive.  “When you’re a teenager, it’s not on your mind,” she said. Had she known, “I migh...
Source: Healthy Living - The Huffington Post - May 12, 2017 Category: Consumer Health News Source Type: news

Hormone replacement therapy may increase risk of hearing loss
A new study, published inMenopause,examines the link between menopausal age, the use of oral hormonal therapy, and hearing loss.Medical News Today (Source: Society for Endocrinology)
Source: Society for Endocrinology - May 11, 2017 Category: Endocrinology Source Type: news

Older age at menopause and use of hormone therapy produce increased risk of hearing loss
It has long been suspected that menopause and the use of hormones had a direct effect on hearing. However, findings from previous studies have been conflicting, with some suggesting that hearing worsens at menopause but that there is benefit with hormone therapy (HT). Now results from the first large population study conducted to assess the association show that older age at natural menopause and the use of oral HT are each associated with a higher risk of hearing loss. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - May 10, 2017 Category: Science Source Type: news

Postmenopausal hormone therapy associated with higher risk of hearing loss
(Brigham and Women's Hospital) Use of postmenopausal hormone therapy was associated with higher risk of hearing loss, and the risk tended to increase with longer duration of use. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 10, 2017 Category: International Medicine & Public Health Source Type: news

Older age at menopause and use of hormone therapy produce increased risk of hearing loss
(The North American Menopause Society (NAMS)) It has long been suspected that menopause and the use of hormones had a direct effect on hearing. However, findings from previous studies have been conflicting, with some suggesting that hearing worsens at menopause but that there is benefit with hormone therapy (HT). Now results from the first large population study conducted to assess the association show that older age at natural menopause and the use of oral HT are each associated with a higher risk of hearing loss. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 10, 2017 Category: International Medicine & Public Health Source Type: news

BMC study finds most transgender patients don't get surgery
Hormonal therapy may be popular for transgender patients, but gender-affirming surgery is not. The findings come from a study performed by Boston Medical Center, which opened the Center for Transgender Medicine and Surgery in 2016. The study looked at 99 transgender patients undergoing hormone therapy at BMC. Researchers noted that the data was collected in the years prior to 2015, before Massachusetts required all insurers to cover medically necessary care for gender transition — such as gender-affirming… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 4, 2017 Category: Biotechnology Authors: Jessica Bartlett Source Type: news

Age of Menopause and Fracture Risk in Postmenopausal Women Age of Menopause and Fracture Risk in Postmenopausal Women
Does the age of menopause onset alter fracture risk in healthy postmenopausal women receiving hormone therapy, calcium and vitamin D supplementation, or a combination?Menopause (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 4, 2017 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Journal Article Source Type: news

How is fracture risk in postmenopausal women affected by genetic factors and hormone therapy?
A study published online in The Journal of Clinical Endocrinology and Metabolism examines the use of menopausal hormone therapy (HT) and genetic links to fracture risk in postmenopausal women.  (Source: Orthogate - Latest News)
Source: Orthogate - Latest News - April 30, 2017 Category: Orthopaedics Tags: Featured Editors Choice News Source Type: news

First Guide to Second-Line Hormonal Therapy for Prostate Cancer
(MedPage Today) -- Fills void in clinical guidance (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - April 25, 2017 Category: Geriatrics Source Type: news

Genetics may be key to hormone therapy for bone fracture in women
A new study by the University at Buffalo found women at the highest genetic risk of bone fracture benefit the most from hormone therapy. (Source: Health News - UPI.com)
Source: Health News - UPI.com - April 24, 2017 Category: Consumer Health News Source Type: news

Genetics are key to hormone therapy lowering risk of broken bones in older women
Women at the highest genetic risk for fracture benefit the most from hormone therapy, according to a first-of-its-kind study. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 24, 2017 Category: Science Source Type: news

Idiopathic hyperprolactinemia increases anterior pituitary hormone deficiency risk
Patients with idiopathic hyperprolactinemia have a higher risk for anterior pituitary hormone deficiency that may require hormone therapy, according to findings published inClinical Endocrinology.Healio (Source: Society for Endocrinology)
Source: Society for Endocrinology - April 24, 2017 Category: Endocrinology Source Type: news

Genetics are key to hormone therapy lowering risk of broken bones in older women
(University at Buffalo) Women at the highest genetic risk for fracture benefit the most from hormone therapy, according to a first-of-its-kind study led by researchers at the University at Buffalo. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - April 24, 2017 Category: Biology Source Type: news

Group Offers Guidance on Treating Primary Ovarian Insufficiency with Hormone Therapy (FREE)
By Kelly Young Edited by Susan Sadoughi, MD, and Andr é Sofair, MD, MPH The American College of Obstetricians and Gynecologists has released new recommendations on using hormone therapy to treat primary ovarian … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - April 24, 2017 Category: Primary Care Source Type: news

Pituitary-testis axis function may improve with GnRH
Men with hypogonadotropic hypogonadism caused by congenital combined pituitary hormone deficiency may see an increase in testosterone levels using gonadotropin-releasing hormone therapy, according to new research.Healio (Source: Society for Endocrinology)
Source: Society for Endocrinology - April 11, 2017 Category: Endocrinology Source Type: news

' Bioidentical' Oral Alternative to Compound Hormones on Horizon'Bioidentical' Oral Alternative to Compound Hormones on Horizon
New oral fixed-dose combinations of 17- β estradiol and natural progesterone are being developed that, if approved, will offer a regulated alternative to compounded hormonal therapy for menopause symptoms.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 10, 2017 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Trial: Abiraterone acetate responses even after initial hormone therapy failure
(University of Colorado Anschutz Medical Campus) Results of a 40-person clinical trial published in JAMA Oncology show that 13 percent of prostate cancer patients deemed 'hormone refractory' did, in fact, have strong responses to treatment with the next-generation hormonal drug abiraterone acetate. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 5, 2017 Category: Global & Universal Source Type: news

Hormone Therapy and Changes in Menopausal Symptoms Over Time Hormone Therapy and Changes in Menopausal Symptoms Over Time
This study compared the efficacy of two forms of menopausal hormone therapy in alleviating vasomotor symptoms, insomnia, and irritability in early postmenopausal women over a period of 4 years.Menopause (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 4, 2017 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Journal Article Source Type: news